Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GeneDx Holdings Corp. (WGS : NSDQ)

• Company Description    GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. Number of Employees: 1,000

• Price / Volume Information    Yesterday's Closing Price: $138.70 Daily Weekly Monthly 20 Day Moving Average: 591,136 shares Shares Outstanding: 28.73 (millions) Market Capitalization: $3,984.33 (millions) Beta: 2.01 52 Week High: $146.00 52 Week Low: $55.17 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.38% 9.62% 12 Week 12.87% 8.65% Year To Date 80.46% 57.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 333 Ludlow Street North Tower 6th Floor - Stamford,CT 06902 USA ph: 888-729-1206 fax: - investors@genedx.com http://www.genedx.com

• General Corporate Information    Officers Katherine Stueland - Chief Executive Officer and Director Jason Ryan - Chairman Kevin Feeley - Chief Financial Officer Eli D. Casdin - Director Emily Leproust - Director Peer Information GeneDx Holdings Corp. (CHCR) GeneDx Holdings Corp. (ESRX) GeneDx Holdings Corp. (MYDP) GeneDx Holdings Corp. (COR) GeneDx Holdings Corp. (GBCS) GeneDx Holdings Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 81663L200 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/17/26 Share - Related Items Shares Outstanding: 28.73 Most Recent Split Date: 5.00 (0.03:1) Beta: 2.01 Market Capitalization: $3,984.33 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.51 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.17 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/17/26

• Fundamental Ratios P/E Current FY Estimate: 118.55 Trailing 12 Months: 70.41 PEG Ratio: - Price Ratios Price/Book: 13.63 Price/Cash Flow: 135.54 Price / Sales: 9.91 EPS Growth vs. Year Ago Period: 1,125.00% vs. Previous Quarter: -2.00% Sales Growth vs. Year Ago Period: 51.86% vs. Previous Quarter: 13.68% ROE 09/30/25 - 20.22 06/30/25 - 16.51 03/31/25 - 10.17 ROA 09/30/25 - 11.89 06/30/25 - 9.35 03/31/25 - 5.51 Current Ratio 09/30/25 - 2.71 06/30/25 - 2.87 03/31/25 - 3.25 Quick Ratio 09/30/25 - 2.59 06/30/25 - 2.70 03/31/25 - 3.07 Operating Margin 09/30/25 - 13.47 06/30/25 - 11.21 03/31/25 - 6.94 Net Margin 09/30/25 - 0.52 06/30/25 - 0.39 03/31/25 - -11.69 Pre-Tax Margin 09/30/25 - 0.62 06/30/25 - 0.42 03/31/25 - -11.63 Book Value 09/30/25 - 10.17 06/30/25 - 9.65 03/31/25 - 9.02 Inventory Turnover 09/30/25 - 10.66 06/30/25 - 10.34 03/31/25 - 10.33 Debt-to-Equity 09/30/25 - 0.18 06/30/25 - 0.19 03/31/25 - 0.20 Debt-to-Capital 09/30/25 - 15.00 06/30/25 - 15.72 03/31/25 - 16.75

Powered by Zacks Investment Research ©